Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
5,554 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02146703 | Gemcitabine and S-1 for Advanced Biliary Tract Cancer | completed | Phase 2 | 38 | Hallym University Medical CenterOTHER | 1 | May 26, 2014 | clinicaltrials |
| NCT02146118 | A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma | unknown | Phase 2 | 42 | MedicalLogicINDUSTRY | 1 | May 23, 2014 | clinicaltrials |
| NCT00504192 | A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer | completed | Phase 2 | 40 | Soonchunhyang University HospitalOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT02141139 | Perioperative Inflammation and Breast Cancer Outcome | unknown | Phase 3 | 1,568 | Samsung Medical CenterOTHER | 1 | May 19, 2014 | clinicaltrials |
| NCT01149122 | Gemcitabine/Oxaliplatin (GEMOX) With or Without Erlotinib (Tarceva) in Advanced Biliary Tract Carcinoma | completed | Phase 3 | 266 | Samsung Medical CenterOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT01711112 | Salvage Docetaxel for Pretreated Urothelial Cancer | completed | Phase 2 | 31 | Samsung Medical CenterOTHER | 1 | May 15, 2014 | clinicaltrials |
| NCT01082809 | Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma | completed | Phase 2 | 59 | Samsung Medical CenterOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT01482520 | Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma | completed | — | 200 | Samsung Medical CenterOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT01758965 | Surgicel® Fibrillar for Delayed Bleeding After ESD | completed | N/A | 146 | Soonchunhyang University HospitalOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT02090010 | Subclavian Vein catheterization_Seldinger Vs Modified Seldinger(MS) | unknown | N/A | 418 | Seoul National University HospitalOTHER | 1 | May 13, 2014 | clinicaltrials |
| NCT00919984 | Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer | terminated | Phase 2 | 22 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01097252 | Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer | completed | Phase 3 | 104 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01194609 | A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer | terminated | Phase 1 / Phase 2 | 2 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT00916500 | Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer | completed | Phase 2 | 71 | Korea Cancer Center HospitalOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT01665300 | Usefulness of Myocardial Deformation Imaging for Trastuzumab-induced Cardiotoxicity | completed | — | 120 | Seoul National University HospitalOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01512069 | Efficacy of a Web-based Tailored Self-management Program | completed | N/A | 59 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01137136 | Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea(CYP19) | suspended | — | 300 | Samsung Medical CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00492752 | A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 3 | 226 | BayerINDUSTRY | 3 | Apr 16, 2014 | clinicaltrials |
| NCT00786838 | A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | completed | Phase 2 | 76 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 7 | Apr 11, 2014 | clinicaltrials |
| NCT01148160 | Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy | terminated | — | 10 | Asan Medical CenterOTHER | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01505413 | Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer(GEMOX-T) | completed | Phase 2 | 33 | Soonchunhyang University HospitalOTHER | 1 | Apr 3, 2014 | clinicaltrials |
| NCT01345214 | A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia | terminated | Phase 1 | 17 | Ono Pharma USA IncINDUSTRY | 3 | Apr 1, 2014 | clinicaltrials |
| NCT00751036 | Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg(MACS0375) | terminated | Phase 3 | 94 | Novartis PharmaceuticalsINDUSTRY | 9 | Mar 26, 2014 | clinicaltrials |
| NCT01790139 | Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles | completed | N/A | 84 | Asan Medical CenterOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT02095379 | Oligosecretary Myeloma: Prevalence and Its Clinical Significance | completed | — | 390 | Samsung Medical CenterOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT01809405 | Validation of Sexual Function Scale in Female Cancer | unknown | — | 1,130 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 20, 2014 | clinicaltrials |
| NCT01532895 | Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid | completed | — | 400 | Janssen Korea, Ltd., KoreaINDUSTRY | 1 | Mar 18, 2014 | clinicaltrials |
| NCT01421680 | The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients | completed | N/A | 144 | Seoul National University HospitalOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | completed | Phase 3 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 28 | Mar 13, 2014 | clinicaltrials |
| NCT01730677 | Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab(LV) | unknown | Phase 2 | 150 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 12, 2014 | clinicaltrials |
| NCT02084355 | Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain | unknown | Phase 3 | 136 | Gyeongsang National University HospitalOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00375999 | Docetaxel and Epirubicin in Advanced Gastric Cancer | completed | Phase 2 | 34 | Yonsei UniversityOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT00995761 | Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 48 | Gyeongsang National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT02076529 | Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting | completed | N/A | 51 | Chonnam National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT00296335 | Trial of Adjuvant Chemotherapy for Gastric Cancer | completed | Phase 3 | 855 | Asan Medical CenterOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | completed | Phase 1 | 55 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Feb 26, 2014 | clinicaltrials |
| NCT00278863 | Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial | completed | Phase 2 | 96 | Asan Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01164475 | Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms | completed | Phase 4 | 61 | Genzyme, a Sanofi CompanyINDUSTRY | 4 | Feb 25, 2014 | clinicaltrials |
| NCT01861223 | Afatinib Plus Nimotuzumb for NSCLC | unknown | Phase 1 / Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02071017 | PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor | unknown | — | 6 | Seoul National University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01692652 | Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate | completed | N/A | 98 | Yonsei UniversityOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01833728 | A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy | completed | N/A | 16 | Yonsei UniversityOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01836406 | Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy | completed | N/A | 16 | Yonsei UniversityOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01634503 | Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3(CIN3) | completed | Phase 1 | 9 | Genexine, Inc.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT02060435 | Epstein-Barr Virus Status in Diffuse Large B Cell Lymphoma | completed | — | 571 | Samsung Medical CenterOTHER | 1 | Feb 12, 2014 | clinicaltrials |
| NCT01409005 | Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer | completed | Phase 2 | 41 | Seoul National University Bundang HospitalOTHER | 1 | Feb 11, 2014 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials